Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Evolus Inc (NASDAQ: EOLS) closed at $9.98 up 1.84% from its previous closing price of $9.80. In other words, the price has increased by $1.84 from its previous closing price. On the day, 1.54 million shares were traded.
Ratios:
For a deeper understanding of Evolus Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 17, 2025, initiated with a Buy rating and assigned the stock a target price of $21.
On January 29, 2024, Barclays Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $10 to $16.
On June 23, 2022, Needham started tracking the stock assigning a Buy rating and target price of $18.Needham initiated its Buy rating on June 23, 2022, with a $18 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 27 ’25 when MOATAZEDI DAVID sold 6,251 shares for $12.40 per share. The transaction valued at 77,512 led to the insider holds 508,619 shares of the business.
Avelar Rui sold 27,904 shares of EOLS for $369,868 on Mar 18 ’25. The insider now owns 362,467 shares after completing the transaction at $13.26 per share. On Mar 18 ’25, another insider, Beaver Sandra, who serves as the Chief Financial Officer of the company, sold 8,996 shares for $13.26 each. As a result, the insider received 119,243 and left with 173,583 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34.
Stock Price History:
Over the past 52 weeks, EOLS has reached a high of $17.82, while it has fallen to a 52-week low of $8.67. The 50-Day Moving Average of the stock is -15.57%, while the 200-Day Moving Average is calculated to be -26.00%.
Shares Statistics:
A total of 64.45M shares are outstanding, with a floating share count of 56.89M. Insiders hold about 11.76% of the company’s shares, while institutions hold 80.66% stake in the company.
Earnings Estimates
Evolus Inc (EOLS) is presently subject to a detailed evaluation by 2.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.04 and -$0.1 for the fiscal current year, implying an average EPS of -$0.06. EPS for the following year is $0.7, with 3.0 analysts recommending between $0.98 and $0.55.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $82.55M this quarter.It ranges from a high estimate of $86.38M to a low estimate of $80.6M. As of the current estimate, Evolus Inc’s year-ago sales were $66.91MFor the next quarter, 6 analysts are estimating revenue of $85.48M. There is a high estimate of $91.18M for the next quarter, whereas the lowest estimate is $82.3M.
A total of 7 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $355M, while the lowest revenue estimate was $345.2M, resulting in an average revenue estimate of $350.09M. In the same quarter a year ago, actual revenue was $266.27MBased on 7 analysts’ estimates, the company’s revenue will be $465.37M in the next fiscal year. The high estimate is $482M and the low estimate is $444.3M.
